D-66201-001 Class II Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-66201-001 was initiated by Hospira Inc. on Aug 29, 2013 and is designated Class II. Reason for recall: Presence of Particulate Matter; report of visible particulates in the glass ampule The recall status is terminated (terminated Nov 10, 2014). Affected quantity: 86,400 ampuls.

Recall Details

Product Type
Drugs
Report Date
Oct 9, 2013
Initiation Date
Aug 29, 2013
Termination Date
Nov 10, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
86,400 ampuls

Product Description

5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2 mL Single Dose Ampuls, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01

Reason for Recall

Presence of Particulate Matter; report of visible particulates in the glass ampule

Distribution Pattern

Nationwide

Code Information

Lot 23-227-DK

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-66201-001
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.